Navigation Links
FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults
Date:1/7/2009

chotic medications, a rare and potentially fatal condition known as Neuroleptic Malignant Syndrome (NMS) has been reported with olanzapine. If signs and symptoms appear, immediate discontinuation is recommended. Clinical manifestations of NMS are hyperpyrexia, muscle rigidity, altered mental status and evidence of autonomic instability (irregular pulse or blood pressure, tachycardia, diaphoresis and cardiac dysrhythmia). Additional signs may include elevated creatinine phosphokinase, myoglobinuria (rhabdomyolysis), and acute renal failure.

Also, as with all antipsychotic treatment, prescribing should be consistent with the need to minimize Tardive Dyskinesia (TD). The risk of developing TD and the likelihood that it will become irreversible are believed to increase as the duration of treatment and the total cumulative dose of antipsychotic increase. The syndrome may remit, partially or completely, if antipsychotic treatment is withdrawn.

Other potentially serious adverse events include seizures, elevated prolactin levels, elevated liver enzymes, cognitive and motor impairment, body temperature elevation, and trouble swallowing.

The most common treatment-emergent adverse event associated with oral Zyprexa in placebo-controlled, short-term schizophrenia and bipolar mania trials was somnolence. Other common events were dizziness, weight gain, personality disorder (COSTART term for nonaggressive objectionable behavior), constipation, akathisia, postural hypotension, dry mouth, asthenia, dyspepsia, increased appetite and tremor.

Full prescribing information, including a boxed warning, is available at www.zyprexa.com.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
2. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
3. European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
4. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
5. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
6. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
8. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
9. European Unions CHMP Issues Positive Opinion on Sugammadex
10. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
11. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 2015 The Coalition of State Rheumatology ... regional professional rheumatology societies, today released the findings ... perceptions of biosimilars and the potential impact of ... Biosimilars are medicines that are highly similar, but ... different from generic medications in that it is ...
(Date:7/1/2015)... 2015 Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... presentation at the Cantor Fitzgerald Healthcare Conference in ... Russell Cox , executive vice president and chief operating ... business and financial update on Wednesday, July 8, 2015 at ... A live audio webcast of the presentation may be accessed ...
(Date:7/1/2015)... 2015 ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ... commercialization of targeted antiviral therapies, announced today that it ... taking place in New York, NY ... Hotel. James Sapirstein , Chief ... business during his live presentation and will be available ...
Breaking Medicine Technology:Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 2ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2
... HILLS, Calif., Sept. 15, 2011 HealthTech Capital, a ... emerging HealthTech market, announced today that it has closed ... from HealthTech Capital members in a Series B syndicated ... while Niveus Medical received $600,000 in a Series A ...
... Sept. 15, 2011 CarePoint Partners (CarePoint), a leading ... that it has acquired Mountain State Infusion Services (Mountain ... 14th acquisition in less than four years. CarePoint now ... and is one of the largest independent infusion therapy ...
Cached Medicine Technology:HealthTech Capital Announces Two New Investments in the Emerging HealthTech Market 2HealthTech Capital Announces Two New Investments in the Emerging HealthTech Market 3CarePoint Partners Expands Coverage in the Ohio Valley Region with Acquisition of Mountain State Infusion Services 2
(Date:7/1/2015)... ... July 01, 2015 , ... Ormco Corporation, ... that its fifth annual Smile for a Lifetime Foundation (S4L) fundraising event held ... In addition to supporting S4L in its mission to provide free quality orthodontic ...
(Date:7/1/2015)... ... July 01, 2015 , ... Renowned rhinoplasty surgeon ... the 2016 Dallas Rhinoplasty Symposium . Set for March 6th - 8th, the ... take participants from the basic training and fundamentals of nasal surgery through the most ...
(Date:7/1/2015)... ... ... The 28th annual Charity Horse Show hosted by the Mid-South Horse Show ... in Pugh Bourne Park, 343 Oakfield Road. The event will again benefit Youth Town. ... a silent auction and concessions. , Horses and riders from around the country will ...
(Date:7/1/2015)... ... ... Trevor L. Williams, DMD holds a Bachelor of Science degree in Biomedical ... degree in Microbiology. He graduated from the University of Florida College of Dentistry in ... Association and the Academy of General Dentistry. Dr. Williams was born in Tampa and ...
(Date:7/1/2015)... ... July 01, 2015 , ... Boar’s ... helping families get ready for Independence Day celebrations with new takes on classic ... versatile options are perfect for any summertime get together. , “Celebrating with family, ...
Breaking Medicine News(10 mins):Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Trevor L. Williams, D.M.D. Joins Enlow & Vance Dental Partners in Tampa, Florida 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 3
... no reduced death risk in patients with localized disease, ... -- Oral sodium clodronate improves overall survival in advanced ... death in those with localized disease, British researchers say. ... more than 800 men enrolled in two trials launched ...
... , KENILWORTH, N.J., Aug. 11 Schering-Plough Corporation ... an antihistamine eye drop strong enough to control itchy eyes all day ... are sold, CLARITIN Eye works in minutes to relieve the itch of ... , To view the Multimedia News Release, go to: ...
... , WASHINGTON, Aug. 11 To gain an insider,s ... publisher of the Guide to Retirement Living SourceBook, will ... downtown Washington, D.C. retirement community. Gurney is documenting his experiences and ... the last 20 years, Gurney has immersed himself in the business ...
... , MOUNTAIN LAKES, N.J., Aug. 11 Today ... -- announces the "3 in 4 Need More" campaign to promote ... big hole in it," says Jonas Roeser, a founding member, "if it ... *(PHOTO 72dpi: Send2Press.com/mediaboom/09-0811-LTCG3in4_72dpi.jpg) , , *(Photo Caption/Cutline: ...
... CARY, N.C., Aug. 11 Cornerstone Therapeutics Inc. (Nasdaq: ... products primarily for the respiratory and related markets, today reported financial results for ... Recent Highlights: , , , ... or 78%, compared to 2008 , , ...
... , HERMOSA BEACH, Calif., Aug. 11 On ... committed to improving the quality of life for Latino children with cancer and ... the 2009 AVP CROCS SLAM BUD LIGHT ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090811/LA59829 ) , , In 2009, AVP named ...
Cached Medicine News:Health News:Oral Drug Ups Survival in Advanced Prostate Cancer Cases 2Health News:Photos: New CLARITIN(R) Eye Relieves Itchy Eyes For Up To 12 Hours 2Health News:Photos: New CLARITIN(R) Eye Relieves Itchy Eyes For Up To 12 Hours 3Health News:Middle-Aged Senior Care Advocate to Move Into D.C. Retirement Community 2Health News:New Health Reform Campaign Will Support Long-Term Care for All, Because '3 in 4 Need More' 2Health News:New Health Reform Campaign Will Support Long-Term Care for All, Because '3 in 4 Need More' 3Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 2Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 3Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 4Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 5Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 6Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 7Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 8Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 9Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 10Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 11Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 12Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 13Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 14Health News:Kevin Nealon, Jordan Farmar, Walter Perez, Cristian de la Fuente and Other Celebrities Participated in Beach Volleyball Match for Children With Cancer 2Health News:Kevin Nealon, Jordan Farmar, Walter Perez, Cristian de la Fuente and Other Celebrities Participated in Beach Volleyball Match for Children With Cancer 3
Inquire...
Inquire...
... anti-reflux valve is enclosed in ... prevents the valve from being ... sitting or reclining positions. The ... interference free ensuring uninterrupted flow ...
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
Medicine Products: